Castle Biosciences Inc.
CSTL | NASDAQ
$34.99
-$0.35 (-0.99%)
At close: Sep 21, 2026, 4:00 PM ET
$34.99
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 14.52M | -14.52M | -2.33M | -501K | 4.52M | -25.85M | 9.59M | 2.27M | 8.92M | -2.53M | -2.58M | -6.91M | -18.78M | -29.2M | -20.62M | -20.25M | -1.65M | -24.62M | -6.43M | -11.79M | -8.79M | -4.28M |
Depreciation & Amortization | -3.93M | 3.93M | 3.78M | 3.82M | 3.41M | 29.76M | 5.77M | 3.54M | 3.35M | 3.34M | 3.22M | 3.17M | 3.04M | 2.89M | 2.84M | 2.92M | 2.63M | 2.15M | 1.45M | 1.09M | 634K | 233K |
Stock-Based Compensation | -9.78M | 9.78M | 11.41M | 12.1M | 11.21M | 11.18M | 11.44M | 13.03M | 13.18M | 12.68M | 11.8M | 13.04M | 12.85M | 13.53M | 9.92M | 9.2M | 8.78M | 8.42M | 6.85M | 5.21M | 4.77M | 4.91M |
Other Working Capital | 23.42M | -23.42M | 9.32M | 8.49M | 5.04M | -17.07M | 4.89M | 5.74M | 6.87M | -14.41M | 7.98M | 3.03M | 6.17M | -10.62M | 5.7M | 1.73M | 7.09M | -7.21M | 3.03M | -766K | 961K | -2.84M |
Other Non-Cash Items | -4.98M | -1.94M | 1.02M | -4.4M | -2.17M | 20K | -2.11M | -1.53M | -1.82M | -1.52M | -1.29M | -1.5M | -1.05M | -1.02M | -1.51M | -188K | -20.37M | 2.57M | -8.64M | -168K | 36K | 33K |
Deferred Income Tax | 10K | -10K | -907K | 116K | -4.67M | -770K | -2.31M | 5.25M | -1.54M | n/a | -236K | n/a | n/a | 13K | -38K | n/a | -1.96M | 123K | n/a | n/a | n/a | n/a |
Change in Working Capital | 19.36M | -19.36M | 13.97M | 11.5M | 8.51M | -20.38M | 1.98M | 776K | 1.91M | -18.8M | 7.67M | -2.8M | 153K | -11.65M | 3.4M | 3.09M | 3.57M | -10.07M | 3.98M | -473K | -3.08M | -4.53M |
Operating Cash Flow | 15.2M | -22.13M | 26.93M | 22.63M | 20.82M | -6.04M | 24.37M | 23.34M | 24M | -6.84M | 18.59M | 5.01M | -3.79M | -25.44M | -6M | -5.22M | -9M | -21.43M | -2.78M | -6.13M | -6.44M | -3.63M |
Capital Expenditures | 12.46M | -12.46M | -7.18M | -14.83M | -9.26M | -4.74M | -7.57M | -6.38M | -5.23M | -9.15M | -3.79M | -2.46M | -4.04M | -3.34M | -1.79M | -2.04M | -1.41M | -402K | -893K | -927K | -913K | -750K |
Cash Acquisitions | -7K | 7K | -1K | 19K | -18.73M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -305K | n/a | n/a | -30M | n/a | -33.18M | n/a |
Purchase of Investments | 55.14M | -55.14M | -37.41M | -58.47M | -44.4M | -48.43M | -47.32M | -45.22M | -52.44M | -60.75M | -52.38M | -50.26M | -56.36M | -30.08M | -2.88M | -131.81M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -41.78M | 41.78M | 55.53M | 54.9M | 44M | 36.3M | 60.65M | 36.8M | 36.25M | 50.2M | 48.5M | 43M | 45M | 50M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -41.77M | n/a | -2.11M | n/a | 12K | -5.56M | 7K | 4K | 2K | 5K | 3K | 2K | 3K | 5K | 186K | 1K | -26.11M | n/a | 4K | 4K | 2K | n/a |
Investing Cash Flow | -15.96M | -25.8M | 8.83M | -18.39M | -28.38M | -22.43M | 5.77M | -14.79M | -21.42M | -19.7M | -7.67M | -9.71M | -15.39M | 16.58M | -4.48M | -134.15M | -27.51M | -402K | -30.89M | -923K | -34.1M | -750K |
Debt Repayment | n/a | -24K | -27K | -31K | -57K | -26K | -26K | -24K | -11K | 9.96M | -36K | -36K | -35K | -35K | -34K | -33K | -31K | -24K | -8K | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -886K | -5.33M | -6.65M | -965K | 139K | -1.55M | -5.73M | 862K | 53K | 680K | -3.26M | 81K | 261K | 763K | -716K | 421K | 692K | 1.24M | 134K | 371K | 537K | 855K |
Financial Cash Flow | -886K | -5.03M | -4.59M | -919K | 101K | -1.55M | -5.39M | 838K | 42K | 10.64M | -3.3M | 45K | 226K | 728K | -750K | 388K | 661K | 1.22M | 126K | 1.89M | 1.89M | 1.51M |
Net Cash Flow | -1.65M | -52.97M | 31.17M | 3.32M | -7.46M | -30.02M | 24.75M | 9.39M | 2.62M | -15.89M | 7.62M | -4.65M | -18.95M | -8.13M | -11.23M | -138.99M | -35.85M | -20.62M | -33.54M | -5.16M | -38.64M | -2.87M |
Free Cash Flow | 27.66M | -34.58M | 19.75M | 7.8M | 11.56M | -10.78M | 16.8M | 16.96M | 18.77M | -15.99M | 14.79M | 2.56M | -7.82M | -28.78M | -7.79M | -7.26M | -10.41M | -21.83M | -3.67M | -7.06M | -7.35M | -4.38M |
Adj. Free Cash Flow | 37.43M | -44.36M | 8.34M | -4.3M | 350K | -21.96M | 5.36M | 3.93M | 5.59M | -28.66M | 2.99M | -10.49M | -20.67M | -42.3M | -17.71M | -16.46M | -19.19M | -30.25M | -10.53M | -12.27M | -12.12M | -9.29M |
Maintenance CapEx | -3.93M | -3.93M | -7.03M | -14.83M | -9.26M | -1.53M | -4.18M | -2.3M | n/a | -3.96M | n/a | n/a | -1.66M | -984.93K | n/a | -70.81K | n/a | n/a | n/a | n/a | n/a | -110.8K |
Growth CapEx | 16.38M | -8.53M | -149.3K | n/a | n/a | -3.21M | -3.39M | -4.08M | -5.23M | -5.19M | -3.79M | -2.46M | -2.37M | -2.35M | -1.79M | -1.97M | -1.41M | -402K | -893K | -927K | -913K | -639.2K |
Owner Earnings | 11.27M | -26.06M | 19.9M | 7.8M | 11.56M | -7.57M | 20.19M | 21.04M | 24M | -10.79M | 18.59M | 5.01M | -5.45M | -26.42M | -6M | -5.29M | -9M | -21.43M | -2.78M | -6.13M | -6.44M | -3.74M |
Add to Watchlist
Select watchlists to add or remove CSTL